Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqi Sherong Pill in Cervical Spondylotic Myelopathy
NCT06377072Phase 3Completed
- Start
- May 2024
- Primary completion
- Jan 2026
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 3 trial of Shenqi Sherong Pill in cervical spondylotic myelopathy (CSM). Started May 2024; status: completed.
02
Drugs
Shenqi Sherong Pill
03
Conditions
cervical spondylotic myelopathy (CSM)
Beyond the preview
Go deeper on NCT06377072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06377072.